CDX2 and cancer: The most frequent copy number alteration in colorectal cancer, amplification at locus 20q11, was observed in 12.5% to 12.9% of non-CDX2-suppressed cancers, but in none of the CDX2-suppressed cases (Fisher’s exact test p = 0.0004).